Friday’s business headlines

INDIANAPOLIS (WISH) – Here’s a look at Friday’s business headlines.

Lilly

The FDA now allows Lilly’s COVID-19 drug to be taken without other treatments.

The FDA has expanded the Emergency Use Authorization for Eli Lilly’s COVID-19 drug, saying it could now be used without taking Gilead’s drug Remdesivir along with it.

In November, the FDA approved the Lilly arthritis drug to treat COVID patients.

The FDA’s expanded use comes after trial data.

The trial those receiving the Lilly treatment were less likely to be put on a ventilator.

Schools

All education loss from school closures will have grave financial implications, McKinsey analysts find that students adversely impacted by school closures could earn $49,000 to $61,000 less over their lifetimes as a result.

This may amount to a $128 billion to $188 billion annual loss to the US economy as the affected generation eventually enters the workforce.

National parks

A boom in national park tourism has left lawmakers wondering how to preserve nature and the visitor experience amid increased traffic, crowds and waiting times.

Bloomberg says reservations, staffing and car limits are pitched as solutions during testimony in a Senate subcommittee hearing.

National park tourism has grown steadily for decades, particularly accelerating in the 2010s. After a brief pandemic lull, visitors have returned to seek fresh air and smashing monthly attendance records at parks.